Home > Boards > US Listed > Medical - Healthcare > SELLAS Life Sciences Group, Inc. (SLS)

Moving on up...0versold now! Been scooping 13/14 lately... Triple bottom...back

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
casenumber Member Profile
 
Followed By 75
Posts 4,141
Boards Moderated 0
Alias Born 06/28/11
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/17/2020 9:00:18 AM
SELLAS Highlights Clinical Development Progress and Expected 2020 Milestones GlobeNewswire Inc. - 1/13/2020 8:30:10 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/10/2020 6:07:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/10/2020 6:03:52 AM
SELLAS Announces Pricing of $6.5 Million Registered Direct Offering Priced At-The-Market GlobeNewswire Inc. - 1/9/2020 9:00:10 AM
SELLAS Commences Pivotal Phase 3 REGAL Study of Galinpepimut-S (GPS) in Patients with Acute Myeloid Leukemia (AML) GlobeNewswire Inc. - 1/8/2020 8:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2020 4:57:24 PM
SELLAS to Present at Biotech Showcase™ GlobeNewswire Inc. - 1/6/2020 8:15:10 AM
SELLAS to Present at the 12th Annual LD Micro Main Event GlobeNewswire Inc. - 12/4/2019 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2019 4:15:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/14/2019 4:37:25 PM
SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2019 Financial Results GlobeNewswire Inc. - 11/14/2019 4:30:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:19:18 PM
SELLAS to Host R&D Investor Event on Galinpepimut-S (GPS) and the Next Generation of Cancer Immunotherapy GlobeNewswire Inc. - 11/8/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 5:01:17 PM
SELLAS Announces Reverse Stock Split GlobeNewswire Inc. - 11/6/2019 9:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 6:05:18 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/30/2019 6:06:04 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/15/2019 6:01:14 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 10/4/2019 5:08:22 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/20/2019 4:14:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2019 4:31:16 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 4:26:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2019 4:20:46 PM
SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2019 Financial Results GlobeNewswire Inc. - 8/14/2019 4:15:00 PM
casenumber   Thursday, 08/29/19 11:52:44 AM
Re: OTC_Buyer post# 1776
Post # of 1970 
Moving on up...0versold now!
Been scooping 13/14 lately...
Triple bottom...back to 20’s in no time ?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist